Why This Wegovy vs Mounjaro Comparison Matters
Wegovy vs Mounjaro Dosage Chart: Core Mechanism Differences
Understanding the wegovy vs mounjaro dosage chart starts with recognising their distinct mechanisms of action. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural incretin hormone to promote satiety and reduce appetite. Mounjaro uses tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects through its broader hormonal pathway activation. This fundamental difference influences not just their dosing schedules but also how they integrate into your weekly routine.
The wegovy vs mounjaro dosage chart reveals Wegovy's streamlined 5-step escalation protocol reaching 2.4mg maintenance, designed for simplicity and proven efficacy in the STEP trial programme. Mounjaro follows a more granular 6-step approach, escalating from 2.5mg to a maximum 15mg maintenance dose, allowing for finer dose adjustments. Both require careful medical supervision during titration phases, which is why our GPhC-registered clinical team (#9012878) reviews every prescription request through our comprehensive online assessment process. Your prescriber can determine which dosing pathway aligns with your tolerance profile and treatment objectives.
Wegovy vs Mounjaro Dosage Chart: Pricing and Value Analysis
When comparing the wegovy vs mounjaro dosage chart from a cost perspective, transparency becomes crucial for treatment planning. Wegovy single pens start at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers benefit from our FIRST40 discount code applied at checkout, while returning customers use DOSE25 for continued savings. Our Getting Started bundles provide convenient dose progression, with the Intro Duo (0.25mg & 0.5mg) available for £169.99.
Mounjaro pricing follows its extended dosing schedule, with costs varying across the six escalation steps from 2.5mg through 15mg maintenance. The wegovy vs mounjaro dosage chart comparison shows both treatments require long-term commitment, making our bundle options particularly valuable for treatment continuity. Our Ultimate Stability Trio offers three months of Wegovy 2.4mg maintenance supply for £649.99, ensuring uninterrupted therapy during the crucial maintenance phase. Both treatments qualify for our temperature-controlled next-day delivery service, maintaining cold-chain integrity from our GPhC-registered facility directly to your door.
Clinical Evidence Supporting Wegovy vs Mounjaro Dosage Chart Selection
The wegovy vs mounjaro dosage chart selection should consider the robust clinical evidence supporting each treatment pathway. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with the 2.4mg maintenance dose demonstrating sustained efficacy (Wilding et al., NEJM, 2021). The STEP 5 extension study showed patients maintained approximately clinically studied weight loss at two years, validating the long-term effectiveness of Wegovy's dosing protocol.
Mounjaro's clinical programme demonstrates the effectiveness of its higher-dose escalation schedule, with the dual receptor approach potentially offering additional metabolic benefits beyond weight management. However, comparing trial weight loss percentages head-to-head isn't appropriate due to different trial designs, patient populations, and endpoint measures. Both treatments are prescription-only medicines requiring clinical assessment and ongoing medical supervision, which our experienced prescribers provide through comprehensive remote consultations and follow-up support.
How Wegovy Works Within the Dosage Chart Framework
Wegovy's mechanism as a GLP-1 receptor agonist directly influences its wegovy vs mounjaro dosage chart positioning and escalation schedule. Once injected weekly, semaglutide binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings between meals. This hormonal signalling may help patients naturally reduce portion sizes and resist emotional eating triggers that often undermine weight management efforts. The 0.25mg starting dose allows your body to gradually adapt to these metabolic changes, minimising potential gastrointestinal side effects during the initial weeks. Each dose escalation in the wegovy vs mounjaro dosage chart represents a carefully calibrated increase designed to optimise therapeutic benefit whilst maintaining tolerability throughout your treatment journey.
EverydayMeds Ordering Process for Both Treatments
Accessing either treatment through our wegovy vs mounjaro dosage chart comparison begins with our streamlined three-minute online clinical assessment, designed by qualified healthcare professionals to evaluate your suitability for prescription weight management therapy. Your responses undergo thorough review by our registered prescribers, typically within three working days (or 24 hours with our express service), ensuring comprehensive evaluation of your medical history, current medications, and treatment goals. Once approved, your chosen prescription ships via our temperature-controlled next-day delivery network, maintaining the cold-chain integrity essential for both Wegovy and Mounjaro stability. Our customer support team remains available throughout your treatment journey, providing guidance on injection techniques, dose escalation timing, and addressing any concerns that may arise during therapy.
Storage and Practical Considerations in Wegovy vs Mounjaro Selection
The wegovy vs mounjaro dosage chart comparison reveals important practical differences affecting daily life and travel flexibility. Wegovy pens require refrigerated storage at 2-8°C before first use but can remain at room temperature below 30°C for up to six weeks once removed from the fridge, providing significant travel convenience for business trips or holidays. Mounjaro offers only 21 days of room temperature stability, requiring more careful planning for extended travel periods. Both treatments use pre-filled injection pens with dose counters, though Wegovy's FlexTouch system offers particularly intuitive operation with audible and tactile feedback during injection. The dose escalation protocols differ significantly, with Wegovy's five-step progression typically taking 16 weeks to reach maintenance versus Mounjaro's potentially longer titration period, affecting your timeline to optimal therapeutic effect.
Side-by-Side Wegovy vs Mounjaro Dosage Chart Comparison
Creating an accurate wegovy vs mounjaro dosage chart comparison requires understanding each treatment's unique escalation pathway and maintenance requirements. Wegovy follows a proven four-week progression: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance from week 17 onwards. This schedule balances efficacy optimisation with tolerability, allowing your body adequate adaptation time between increases. Mounjaro's six-step approach provides more granular dose adjustments, potentially beneficial for patients requiring careful titration due to sensitivity concerns or concurrent medical conditions.
The wegovy vs mounjaro dosage chart comparison also highlights injection timing flexibility, with both treatments administered once weekly on the same day each week, regardless of meal timing. However, the pen designs, storage requirements, and dose escalation intervals differ enough to influence treatment preference and lifestyle compatibility. Both treatments require prescription-only medicine authorisation and ongoing medical supervision, which our GPhC-registered clinical team provides through regular progress reviews and dose adjustment guidance based on your individual response and tolerance profile.
Making Your Wegovy vs Mounjaro Choice with Professional Support
Ultimately, the wegovy vs mounjaro dosage chart serves as a framework for informed discussion with qualified healthcare professionals rather than a definitive treatment selector. EverydayMeds offers both treatments precisely because individual patient needs, medical histories, and treatment responses vary significantly—what works optimally for one person may not be the ideal choice for another. Our prescribers consider factors including your BMI, weight-related comorbidities, previous weight management attempts, concurrent medications, and lifestyle preferences when recommending the most appropriate treatment pathway. The comprehensive clinical assessment process ensures you receive personalised medical advice tailored to your specific circumstances and health objectives. Both Wegovy and Mounjaro are available from EverydayMeds with identical service standards, cold-chain delivery, and ongoing clinical support—your prescriber can help determine which treatment pathway aligns best with your individual needs and treatment goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
